Quarterly report pursuant to Section 13 or 15(d)

Basic and Diluted Net Loss Per Share (Tables)

v3.20.2
Basic and Diluted Net Loss Per Share (Tables)
6 Months Ended
Jun. 30, 2020
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Net Loss Per Share

The following table sets forth the computation of the Company’s basic and diluted net loss per share for:

 

    Three-months ended June 30, 2020 (Unaudited)  
    Net Loss (Numerator)     Shares (Denominator)     Per share
amount
 
Basic loss per share   $ (1,700,342 )     753,222     $ (2.26 )
Effect of dilutive securities—Common stock options, warrants, and convertible notes     -       -       -  
Diluted loss per share   $ (1,700,342 )     753,222     $ (2.26 )

 

    Three-months ended June 30, 2019 (Unaudited)  
    Net Loss (Numerator)     Shares (Denominator)     Per share
amount
 
Basic loss per share   $ (1,081,694 )     680,186     $ (1.59 )
Effect of dilutive securities—Common stock options, warrants, and convertible notes     -       -       -  
Diluted loss per share   $ (1,081,694 )     680,186     $ (1.59 )

 

    Six-months ended June 30, 2020 (Unaudited)  
    Net Loss (Numerator)     Shares (Denominator)     Per share
amount
 
Basic loss per share   $ (2,703,210 )     727,050     $ (3.72 )
Effect of dilutive securities—Common stock options, warrants, and convertible notes     -       -       -  
Diluted loss per share   $ (2,703,210 )     727,050     $ (3.72 )

 

    Six-months ended June 30, 2019 (Unaudited)  
    Net Loss (Numerator)     Shares (Denominator)     Per share
amount
 
Basic loss per share   $ (2,217,114 )     675,250     $ (3.28 )
Effect of dilutive securities—Common stock options, warrants, and convertible notes     -       -       -  
Diluted loss per share   $ (2,217,114 )     675,250     $ (3.28 )
Schedule of Shares of Common Stock Equivalents Were Excluded from the Computation of Diluted Net Loss Per Share

The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented because including them would have been antidilutive for the periods ended:

 

    June 30, 2020     June 30, 2019  
      (Unaudited)       (Unaudited)  
Common stock underlying convertible notes     439,137       6,250  
Common stock underlying options     175,544       202,537  
Common stock underlying warrants     480,748       504,875  
Total common stock equivalents     1,095,429       713,662